Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 4783 results
Production of Monoclonal or Recombinant Antibodies
Production of monoclonal antibodies and antibody derivates can be carried out using a variety of mammalian cell lines, ranging from the widely-used CHO-cells to our proprietary human cells, ensuring a glyco-optimisation.
Drug Research > Drug Discovery & Development > Products
Production of Other Recombinant Biotherapeutics
As well as our expertise in the production of antibodies, Glycotope Biotechnology is continually producing a variety of other therapeutic molecules, such as cytokines and peptide hormones.
Drug Research > Drug Discovery & Development > Products
Protein Analytical Services
For demonstration and documentation of the batch-to-batch consistency of any given biopharmaceutical material, its identity, purity, quantity, bioactivity and profile of impurities must be confirmed.
Drug Research > Drug Discovery & Development > Products
Boehringer Ingelheim receives orphan drug designation for volasertib in US and EU
By PBR Staff Writer
Boehringer Ingelheim Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) and the European Commission for its volasertib for the treatment of acute myeloid leukemia (AML).
Drug Research > Drug Discovery & Development > News
Islet Sciences reports results from two Phase IIb clinical studies for type 2 diabetics drug
By PBR Staff Writer
Islet Sciences and BHV Pharma have reported positive data from the two 12-week Phase IIb clinical studies of SGLT2 inhibitor remogliflozin etabonate in type 2 diabetics.
Drug Research > Drug Discovery & Development > News
OxThera secures $10m investment to continue clinical programs
By PBR Staff Writer
Swedish biopharmaceutical firm OxThera has received SEK70m ($10m) from a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, to continue its major clinical programs.
Drug Research > Drug Discovery & Development > News
Iconic Therapeutics raises $20m to advance clinical development of wet AMD program
Iconic Therapeutics has announced that it has successfully completed a $20m Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.
Drug Research > Drug Discovery & Development > News
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.
Drug Research > Drug Discovery & Development > Suppliers
DesignMedix gets $3m NIH grant to develop low-cost malaria drug
By PBR Staff Writer
US-based biotech startup DesignMedix has received a grant of $3m from the National Institutes of Health (NIH) to continue the development and manufacturing of a new anti-malarial drug.
Drug Research > Drug Discovery & Development > News
Transdermal Technologies
LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. We are continually developing our TTS and OTF as well as microneedle technologies.
Drug Research > Drug Discovery & Development > Products
Oral Thin Films for Drug Delivery
Oral thin films (OTF) are loaded with active substances which are used for drug delivery. They are taken orally and dissolve immediately in the mouth or are applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal tract.
Drug Research > Drug Discovery & Development > Products
Drug Delivery via Transdermal Therapeutic Systems
Transdermal patches or transdermal therapeutic systems (TTS) are drug delivery systems that are applied directly to the skin. The active substance is absorbed by the skin and is distributed through the body transdermally via the bloodstream. This unique mode of administration has improved the simplicity of treatment for patients for almost 30 years.
Drug Research > Drug Discovery & Development > Products
Kineta and RLB Holdings announce new joint venture
Kineta, a biotechnology company focused on the development of immune modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture Kineta RLB, which will commercialize promising, high value compounds in selective disease areas with unmet medical needs.
Drug Research > Drug Discovery & Development > News
Mast Therapeutics announces new data supporting MST-188 in sickle cell disease
Mast Therapeutics has announced that, in an ex vivo study conducted at Loyola University Medical Center, MST-188 reduced the mean erythrocyte sedimentation rate (ESR) by 50% relative to control in blood collected from individuals with sickle cell disease.
Drug Research > Drug Discovery & Development > News
Ipsen presents first set of results on Phase III clinical study of Dysport
By PBR Staff Writer
Ipsen has reported the first set of results on Phase III clinical study of Dysport, an injectable form of botulinum toxin type A (BoNT-A), in the treatment of adults suffering from upper limb spasticity at the 8th World Congress for NeuroRehabilitation in Istanbul, Turkey.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Discovery & Development > Suppliers
Glycotope - Contract Manufacturer of Recombinant Proteins
Glycotope Biotechnology offers GMP-compliant biotechnological contract manufacturing, based on animal cell culture systems in fed-batch or perfusion fermentation technologies. We are compliant with all criteria within the European Pharmaceutical legislation, the European Pharmacopoeia, as well as EU and ICH guidelines.... Drug Research > Drug Discovery & Development > Suppliers
The Electrospinning Company - Polymer Scaffolds for 3D Cell Culture
The Electrospinning Company develops and manufactures electrospun polymer scaffolds which are incorporated into standard tissue culture plates. These provide an ideal environment for supporting the growth of cells in 3D.... Drug Research > Drug Discovery & Development > Suppliers
Natoli - Expert Insight When You Need it Most
Natoli Engineering Company has over 35 years of experience in delivering quality tablet compression products and services to pharmaceutical, nutritional, veterinary, confectionary, and industrial customers around the globe. Natoli's commitment to providing the highest quality products with expert technical service ensures their customers get the very most from their equipment.... Drug Research > Drug Discovery & Development > Suppliers
Polygon Medical Animation - 3D Medical Animation, Illustration and Interactive
Polygon is a full-service provider of first-class, mechanism of action (MOA), 3D medical animation and illustration for the pharmaceutical and biotech industry, as well as educational institutes, worldwide.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Contract Manufacturing By LABORATORIOS INIBSA
LABORATORIOS INIBSA is a pharmaceutical company with over 60 years of experience. We belong to the Group Inibsa. We provide products and services to group companies, such as Biotools, Keramat, Inibsa Portugal, Dental and Hospital, as well as other pharmaceutical companies through our contract manufacturing division.... Drug Research > Drug Discovery & Development > White Papers Signed by Syncom - Designing Chemistry in 25 Milestones By Syncom BV pbr
There are so many reasons to be proud of this company. In the first 25 years of Syncoms’ existence, we have truly made a contribution to science, the pharmaceutical industry, the health of many people across all continents, to the economy of our city (Groningen), as well as to the careers and lives of employees and former employees.... Drug Research > Drug Discovery & Development > White Papers Syncom Catalogue By Syncom BV pbr
Click here to download our catalogue of products.... Drug Research > Drug Discovery & Development > White Papers Softigel Technologies Brochure By Softigel pbr
From selecting the best gelatin source, throughout the soft gelatin capsule development, manufacturing, labeling and packaging process, until delivering a final product to your warehouse with supporting marketing strategies, SoftiGel is vertically integrated to fulfill your needs and deliver the best drug to any marketplace in the world.... Drug Research > Drug Discovery & Development > White Papers SoftiGel Product Catalogue By Softigel pbr
Download our whitepaper for details of our pharmaceutical capsules and products.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 4783 results